Crosstalk between Helicobacter pylori and Gastric Epithelial Cells Is Impaired by Docosahexaenoic Acid

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Correia, Marta ^a,b,c   Michel, Valérie ^c   Osório, Hugo ^a,b   El Ghachi, Meriem ^c,d   Bonis, Mathilde ^c,d   Boneca, Ivo G ^c,d   de Reuse, Hilde ^c   Matos, António A ^e,f   Lenormand, Pascal ^c   Seruca, Raquel ^a,b   Figueiredo, Ceu ^a,b   Machado, Jose Carlos ^a,b   Touati, Eliette ^c  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c INSTITUT PASTEUR   (France)

^d INSERM   (France)

^e Universidade de Lisboa   (Portugal)

^f UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIUM LIPOPOLYSACCHARIDE; CATALASE; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 8; METHIONYL AMINOPEPTIDASE; OUTER MEMBRANE PROTEIN; PROTEIN DNAK;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM ADHERENCE; CELL INTERACTION; CELL STRESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; IMMUNOBLOTTING; INFLAMMATION; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; QUANTITATIVE ANALYSIS; STOMACH EPITHELIUM; STRAIN DIFFERENCE; TRANSMISSION ELECTRON MICROSCOPY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTI-INFLAMMATORY AGENTS; BACTERIAL ADHESION; BACTERIAL OUTER MEMBRANE PROTEINS; CELL WALL; DOCOSAHEXAENOIC ACIDS; EPITHELIAL CELLS; HELICOBACTER PYLORI; INFLAMMATION; STOMACH;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 84875962309     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060657     Document Type: Article

References (51)

1. Peek RM Jr, Blaser MJ, (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28-37.
2. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, et al. (2009) Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 151: 121-128.
3. Tulassay Z, Stolte M, Engstrand L, Butruk E, Malfertheiner P, et al. (2010) Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers. Scand J Gastroenterol 45: 1048-1058.
4. Wang J, Xu L, Shi R, Huang X, Li SW, et al. (2011) Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 83: 253-260.
5. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, et al. (2012) Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 61: 646-664.
6. Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, et al. (2012) Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut.
7. Graham DY, Fischbach L, (2010) Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 59: 1143-1153.
8. Persson C, Canedo P, Machado JC, El-Omar EM, Forman D, (2011) Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. Am J Epidemiol 173: 259-270.
9. McLean MH, El-Omar EM, (2011) Genetics of inflammation in the gastrointestinal tract and how it can cause cancer. Recent Results Cancer Res 185: 173-183.
10. Shimada T, Terano A, (1998) Chemokine expression in Helicobacter pylori-infected gastric mucosa. J Gastroenterol 33: 613-617.
11. Jung HC, Kim JM, Song IS, Kim CY, (1997) Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8,-1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-alpha. J Gastroenterol Hepatol 12: 473-480.
12. Kim JS, Jung HC, Kim JM, Song IS, Kim CY, (2000) Helicobacter pylori water-soluble surface proteins activate human neutrophils and up-regulate expression of CXC chemokines. Dig Dis Sci 45: 83-92.
13. Thompson L, Cockayne A, Spiller RC, (1994) Inhibitory effect of polyunsaturated fatty acids on the growth of Helicobacter pylori: a possible explanation of the effect of diet on peptic ulceration. Gut 35: 1557-1561.
14. Barber MD, Fearon KC, Ross JA, (2005) Eicosapentaenoic acid modulates the immune response but has no effect on a mimic of antigen-specific responses. Nutrition 21: 588-593.
15. Kuriki K, Wakai K, Matsuo K, Hiraki A, Suzuki T, et al. (2007) Gastric cancer risk and erythrocyte composition of docosahexaenoic acid with anti-inflammatory effects. Cancer Epidemiol Biomarkers Prev 16: 2406-2415.
16. Simopoulos AP, (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21: 495-505.
17. Correia M, Michel V, Matos AA, Carvalho P, Oliveira MJ, et al. (2012) Docosahexaenoic Acid Inhibits Helicobacter pylori Growth In Vitro and Mice Gastric Mucosa Colonization. PLoS One 7: e35072.
18. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, et al. (1997) A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112: 1386-1397.
19. Israel DA, Salama N, Arnold CN, Moss SF, Ando T, et al. (2001) Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest 107: 611-620.
20. McGuckin MA, Every AL, Skene CD, Linden SK, Chionh YT, et al. (2007) Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology 133: 1210-1218.
21. Stingl K, Schauer K, Ecobichon C, Labigne A, Lenormand P, et al. (2008) In vivo interactome of Helicobacter pylori urease revealed by tandem affinity purification. Mol Cell Proteomics 7: 2429-2441.
22. El Ghachi M, Mattei PJ, Ecobichon C, Martins A, Hoos S, et al. (2011) Characterization of the elongasome core PBP2: MreC complex of Helicobacter pylori. Mol Microbiol 82: 68-86.
23. Edwards NJ, Monteiro MA, Faller G, Walsh EJ, Moran AP, et al. (2000) Lewis X structures in the O antigen side-chain promote adhesion of Helicobacter pylori to the gastric epithelium. Mol Microbiol 35: 1530-1539.
24. Lesse AJ, Campagnari AA, Bittner WE, Apicella MA, (1990) Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Immunol Methods 126: 109-117.
25. Tsai CM, Frasch CE, (1982) A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119: 115-119.
26. Pinho SS, Osorio H, Nita-Lazar M, Gomes J, Lopes C, et al. (2009) Role of E-cadherin N-glycosylation profile in a mammary tumor model. Biochem Biophys Res Commun 379: 1091-1096.
27. Nakachi N, Klein TW, Friedman H, Yamamoto Y, (2000) Helicobacter pylori infection of human gastric epithelial cells induces IL-8 and TNFalpha, but not TGFbeta1 mRNA. FEMS Immunol Med Microbiol 29: 23-26.
28. Schauer K, Gouget B, Carriere M, Labigne A, de Reuse H, (2007) Novel nickel transport mechanism across the bacterial outer membrane energized by the TonB/ExbB/ExbD machinery. Mol Microbiol 63: 1054-1068.
29. Pflock M, Bathon M, Schar J, Muller S, Mollenkopf H, et al. (2007) The orphan response regulator HP1021 of Helicobacter pylori regulates transcription of a gene cluster presumably involved in acetone metabolism. J Bacteriol 189: 2339-2349.
30. Waidner B, Specht M, Dempwolff F, Haeberer K, Schaetzle S, et al. (2009) A novel system of cytoskeletal elements in the human pathogen Helicobacter pylori. PLoS Pathog 5: e1000669.
31. de Bernard M, D'Elios MM, (2010) The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe? Toxicon 56: 1186-1192.
32. Amedei A, Cappon A, Codolo G, Cabrelle A, Polenghi A, et al. (2006) The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 116: 1092-1101.
33. Moran AP, (1996) The role of lipopolysaccharide in Helicobacter pylori pathogenesis. Aliment Pharmacol Ther 10 (Suppl 1):: 39-50.
34. Cabeen MT, Jacobs-Wagner C, (2005) Bacterial cell shape. Nat Rev Microbiol 3: 601-610.
35. Fosslien E, (2001) Mitochondrial medicine-molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 31: 25-67.
36. Leduc D, Gallaud J, Stingl K, de Reuse H, (2010) Coupled amino acid deamidase-transport systems essential for Helicobacter pylori colonization. Infect Immun 78: 2782-2792.
37. Kim KM, Lee SG, Kim JM, Kim DS, Song JY, et al. (2010) Helicobacter pylori gamma-glutamyltranspeptidase induces cell cycle arrest at the G1-S phase transition. J Microbiol 48: 372-377.
38. Kim KM, Lee SG, Park MG, Song JY, Kang HL, et al. (2007) Gamma-glutamyltranspeptidase of Helicobacter pylori induces mitochondria-mediated apoptosis in AGS cells. Biochem Biophys Res Commun 355: 562-567.
39. Boonyanugomol W, Chomvarin C, Song JY, Kim KM, Kim JM, et al. (2012) Effects of Helicobacter pylori gamma-Glutamyltranspeptidase on Apoptosis and Inflammation in Human Biliary Cells. Dig Dis Sci.
40. Shibayama K, Wachino J, Arakawa Y, Saidijam M, Rutherford NG, et al. (2007) Metabolism of glutamine and glutathione via gamma-glutamyltranspeptidase and glutamate transport in Helicobacter pylori: possible significance in the pathophysiology of the organism. Mol Microbiol 64: 396-406.
41. Gancz H, Merrell DS, (2011) The Helicobacter pylori Ferric Uptake Regulator (Fur) is essential for growth under sodium chloride stress. J Microbiol 49: 294-298.
42. Waidner B, Greiner S, Odenbreit S, Kavermann H, Velayudhan J, et al. (2002) Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infect Immun 70: 3923-3929.
43. Seo JY, Yu JH, Lim JW, Mukaida N, Kim H, (2009) Nitric oxide-induced IL-8 expression is mediated by NF-kappaB and AP-1 in gastric epithelial AGS cells. J Physiol Pharmacol 60 (Suppl 7):: 101-106.
44. Ambs S, Merriam W, Bennet W, Felley-Bosco E, Ogunfusika M, et al. (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication fo tumor angiogenesis and colon cancer progression. Cancer Research 58: 334-341.
45. Spencer L, Mann C, Metcalfe M, Webb M, Pollard C, et al. (2009) The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer 45: 2077-2086.
46. Hwang SW, Kim N, Kim JM, Huh CS, Ahn YT, et al. (2012) Probiotic suppression of the H. pylori-induced responses by conjugated linoleic acids in a gastric epithelial cell line. Prostaglandins Leukot Essent Fatty Acids 86: 225-231.
47. Lee JY, Hwang DH, (2006) The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol Cells 21: 174-185.
48. Sun CQ, O'Connor CJ, Roberton AM, (2003) Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol 36: 9-17.
49. Aires V, Hichami A, Moutairou K, Khan NA, (2003) Docosahexaenoic acid and other fatty acids induce a decrease in pHi in Jurkat T-cells. Br J Pharmacol 140: 1217-1226.
50. Petschow BW, Batema RP, Ford LL, (1996) Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agents Chemother 40: 302-306.
51. Erah PO, Goddard AF, Barrett DA, Shaw PN, Spiller RC, (1997) The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. J Antimicrob Chemother 39: 5-12.